Market Closed -
Nyse
04:00:02 2024-05-17 pm EDT
|
5-day change
|
1st Jan Change
|
5.76
USD
|
-0.69%
|
|
+6.86%
|
-17.12%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,505
|
1,117
|
1,175
|
980.5
|
-
|
-
|
Enterprise Value (EV)
1 |
4,310
|
957.2
|
1,175
|
730.9
|
674.9
|
624.2
|
P/E ratio
|
-459
x
|
61.2
x
|
57.9
x
|
100
x
|
48.7
x
|
37.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.7
x
|
2.21
x
|
2.15
x
|
1.8
x
|
1.72
x
|
1.64
x
|
EV / Revenue
|
10.3
x
|
1.89
x
|
2.15
x
|
1.34
x
|
1.19
x
|
1.04
x
|
EV / EBITDA
|
40.9
x
|
11
x
|
13.7
x
|
13.2
x
|
9.38
x
|
8.04
x
|
EV / FCF
|
67.6
x
|
-23.5
x
|
-
|
24.7
x
|
13.5
x
|
21.3
x
|
FCF Yield
|
1.48%
|
-4.25%
|
-
|
4.06%
|
7.43%
|
4.7%
|
Price to Book
|
17.9
x
|
4.1
x
|
-
|
2.3
x
|
2.05
x
|
1.82
x
|
Nbr of stocks (in thousands)
|
163,457
|
165,963
|
169,135
|
170,228
|
-
|
-
|
Reference price
2 |
27.56
|
6.730
|
6.950
|
5.760
|
5.760
|
5.760
|
Announcement Date
|
3/8/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
419.6
|
505.8
|
545.6
|
545.3
|
568.5
|
599.2
|
EBITDA
1 |
105.2
|
87.25
|
86
|
55.49
|
71.91
|
77.63
|
EBIT
1 |
10.98
|
37.67
|
34.04
|
10.13
|
28.14
|
35.1
|
Operating Margin
|
2.62%
|
7.45%
|
6.24%
|
1.86%
|
4.95%
|
5.86%
|
Earnings before Tax (EBT)
1 |
9.859
|
38.73
|
40.81
|
18.8
|
35.07
|
39.58
|
Net income
1 |
-9.556
|
21.19
|
22.64
|
11.22
|
22.76
|
28.81
|
Net margin
|
-2.28%
|
4.19%
|
4.15%
|
2.06%
|
4%
|
4.81%
|
EPS
2 |
-0.0600
|
0.1100
|
0.1200
|
0.0575
|
0.1183
|
0.1550
|
Free Cash Flow
1 |
63.72
|
-40.68
|
-
|
29.65
|
50.16
|
29.35
|
FCF margin
|
15.19%
|
-8.04%
|
-
|
5.44%
|
8.82%
|
4.9%
|
FCF Conversion (EBITDA)
|
60.55%
|
-
|
-
|
53.43%
|
69.75%
|
37.81%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
264.29%
|
220.33%
|
101.87%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/8/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
128.7
|
110.1
|
122.2
|
128.6
|
144.9
|
120.2
|
138.1
|
142.4
|
144.9
|
119.3
|
142.3
|
136.3
|
146.9
|
122.6
|
149.5
|
EBITDA
1 |
31.9
|
24.98
|
21.48
|
21.02
|
19.76
|
16.08
|
18.9
|
24.42
|
26.6
|
12.99
|
12.11
|
11.41
|
18.42
|
13.63
|
19.3
|
EBIT
1 |
16.43
|
13.74
|
9.451
|
11.21
|
3.26
|
3.297
|
6.566
|
9.954
|
14.23
|
0.443
|
0.3309
|
0.827
|
7.536
|
2.627
|
8.2
|
Operating Margin
|
12.77%
|
12.48%
|
7.73%
|
8.72%
|
2.25%
|
2.74%
|
4.75%
|
6.99%
|
9.82%
|
0.37%
|
0.23%
|
0.61%
|
5.13%
|
2.14%
|
5.49%
|
Earnings before Tax (EBT)
1 |
16.31
|
13.75
|
9.521
|
11.82
|
3.638
|
4.368
|
8.083
|
11.85
|
16.51
|
3.28
|
1.115
|
2.733
|
8.675
|
2.433
|
9.2
|
Net income
1 |
12.6
|
8.899
|
4.852
|
4.044
|
3.391
|
1.909
|
4.582
|
6.146
|
10
|
1.435
|
0.6236
|
1.728
|
5.609
|
1.76
|
6.191
|
Net margin
|
9.79%
|
8.08%
|
3.97%
|
3.14%
|
2.34%
|
1.59%
|
3.32%
|
4.32%
|
6.9%
|
1.2%
|
0.44%
|
1.27%
|
3.82%
|
1.44%
|
4.14%
|
EPS
2 |
0.0600
|
0.0500
|
0.0300
|
0.0200
|
0.0200
|
0.0100
|
0.0200
|
0.0300
|
0.0500
|
0.0100
|
0.003330
|
0.005000
|
0.0340
|
0.0100
|
0.0300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/8/22
|
5/12/22
|
8/4/22
|
11/10/22
|
2/28/23
|
5/4/23
|
8/3/23
|
11/2/23
|
2/28/24
|
5/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
195
|
160
|
-
|
250
|
306
|
356
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
63.7
|
-40.7
|
-
|
29.6
|
50.2
|
29.3
|
ROE (net income / shareholders' equity)
|
-5.57%
|
7.66%
|
-
|
2.18%
|
4.39%
|
5.83%
|
ROA (Net income/ Total Assets)
|
-
|
6%
|
-
|
2.5%
|
3.9%
|
4.9%
|
Assets
1 |
-
|
353.4
|
-
|
448.7
|
583.7
|
587.9
|
Book Value Per Share
2 |
1.540
|
1.640
|
-
|
2.500
|
2.810
|
3.160
|
Cash Flow per Share
2 |
0.4200
|
-0.1900
|
-
|
0.2700
|
0.3500
|
-
|
Capex
1 |
2.71
|
5.35
|
-
|
17.5
|
11.5
|
19.5
|
Capex / Sales
|
0.65%
|
1.06%
|
-
|
3.21%
|
2.02%
|
3.25%
|
Announcement Date
|
3/8/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
5.76
USD Average target price
5.688
USD Spread / Average Target -1.26% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.12% | 981M | | +10.10% | 27.85B | | -31.01% | 3.09B | | +35.19% | 2.66B | | -18.85% | 2.44B | | +6.85% | 2.24B | | +33.33% | 2.05B | | -4.71% | 2.02B | | +34.05% | 1.35B | | +3.08% | 1.33B |
Medical Supplies
|